2018 Annual Meeting | C244 - Joint AAN and AHA/ASA Session: Bridging Racial and Ethnic Disparities in the Management of Stroke and Breakthroughs in Engaging Minority and Rural Communities in Stroke
| 03:30 PM - 03:45 PM | Speaker |
State of Racial and Ethnic Disparities in Stroke
Salvador Cruz-Flores, MD, FAAN |
| 03:45 PM - 04:00 PM | Speaker |
What More Can Be Done to Address Racial and Ethnic Disparities in Stroke?
|
| 04:00 PM - 04:15 PM | Speaker |
Avenues to Engage in Stroke Disparities Research
Olajide A. Williams, MD |
| 04:15 PM - 04:30 PM | Speaker |
Obstacles and Opportunities in Stroke Care Access among Racial and Ethnic Minorities
Enrique C. Leira, MD, MS, FAAN |
| 04:30 PM - 04:45 PM | Speaker |
Learning About Your Community (And Establishing a Community Advisory Board)
Olajide A. Williams, MD |
| 04:45 PM - 05:00 PM | Speaker |
Captivating the Community and Sustaining Ties
Bernadette Boden-Albala, DrPH |
| 05:00 PM - 05:15 PM | Speaker |
Building Trust With Your Community Through Communication
Brett M. Kissela, MD, MS, FAAN |
| 05:15 PM - 05:30 PM | Speaker |
Dissemination of Results and Presenting Information
Stephen Sidney, MD, MPH |
| Devin L. Brown, MD, FAAN | The institution of Dr. Brown has received research support from NIH. |
| Claudia Moy, PhD | Claudia Moy, PhD has nothing to disclose. |
| Brett M. Kissela, MD, MS, FAAN | The institution of Dr. Kissela has received research support from NIH/NINDS. |
| Salvador Cruz-Flores, MD, FAAN | The institution of Dr. Cruz-Flores has received research support from University of Texas System. |
| Amy T. Towfighi, MD | Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NIH. |
| No disclosure on file | |
| Bernadette Boden-Albala, DrPH | Ms. Boden-Albala has received research support from NIH. |
| Arleen Brown | No disclosure on file |
| Bruce I. Ovbiagele, MD, MSc, FAAN | Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities. |
| Virginia J. Howard, PhD | The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH. |
| Philip B. Gorelick, MD, MPH, FAAN | Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital. |
| George Howard, PhD | Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. |
| Enrique C. Leira, MD, MS, FAAN | Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS. |
| Lesli E. Skolarus, MD, MS | The institution of Dr. Skolarus has received research support from NIH. |
| Stephen Sidney, MD, MPH | Dr. Sidney has nothing to disclose. |
| Barbara G. Vickrey, MD, MPH, FAAN | The institution of Dr. Vickrey has received research support from NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a Grant reviewer, committee co-chair with NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a conference advisory committee with University of Rochester. Dr. Vickrey has a non-compensated relationship as a Second Vice President with Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee member of Stroke Council with American Heart Association that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee Chair with American Neurological Association that is relevant to AAN interests or activities. |
| Olajide A. Williams, MD | Dr. Williams has nothing to disclose. |
| Jose G. Romano, MD, FAAN | Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI. |